RHN-002

N/A

Report date: 2023/09/11 16:53:02
NME

Base Information

Drug NameRHN-002
Drug Alias NameRHN-002RHN002
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsPain, PostoperativeAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRH Nanopharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesRH Nanopharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsPain, PostoperativeAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A